Cargando…

Caplacizumab use for immune thrombotic thrombocytopenic purpura: the Milan thrombotic thrombocytopenic purpura registry

• Data on caplacizumab use for thrombotic thrombocytopenic purpura (TTP) in Italy are missing. • Twenty-six Italian patients were treated with caplacizumab for an acute immune TTP episode. • Caplacizumab was effective in treating acute TTP in the Italian real-world clinical setting. • Two major blee...

Descripción completa

Detalles Bibliográficos
Autores principales: Agosti, Pasquale, De Leo, Pasqualina, Capecchi, Marco, Ferrari, Barbara, Mancini, Ilaria, Gattillo, Salvatore, Trisolini, Silvia Maria, Rinaldi, Erminia, Podda, Gian Marco, Prezioso, Lucia, Salutari, Prassede, Facchini, Luca, Caramazza, Domenica, Tolomelli, Giulia, Artoni, Andrea, Peyvandi, Flora
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10502422/
https://www.ncbi.nlm.nih.gov/pubmed/37720483
http://dx.doi.org/10.1016/j.rpth.2023.102185
_version_ 1785106320511205376
author Agosti, Pasquale
De Leo, Pasqualina
Capecchi, Marco
Ferrari, Barbara
Mancini, Ilaria
Gattillo, Salvatore
Trisolini, Silvia Maria
Rinaldi, Erminia
Podda, Gian Marco
Prezioso, Lucia
Salutari, Prassede
Facchini, Luca
Caramazza, Domenica
Tolomelli, Giulia
Artoni, Andrea
Peyvandi, Flora
author_facet Agosti, Pasquale
De Leo, Pasqualina
Capecchi, Marco
Ferrari, Barbara
Mancini, Ilaria
Gattillo, Salvatore
Trisolini, Silvia Maria
Rinaldi, Erminia
Podda, Gian Marco
Prezioso, Lucia
Salutari, Prassede
Facchini, Luca
Caramazza, Domenica
Tolomelli, Giulia
Artoni, Andrea
Peyvandi, Flora
author_sort Agosti, Pasquale
collection PubMed
description • Data on caplacizumab use for thrombotic thrombocytopenic purpura (TTP) in Italy are missing. • Twenty-six Italian patients were treated with caplacizumab for an acute immune TTP episode. • Caplacizumab was effective in treating acute TTP in the Italian real-world clinical setting. • Two major bleeds leading to drug discontinuation were observed.
format Online
Article
Text
id pubmed-10502422
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-105024222023-09-16 Caplacizumab use for immune thrombotic thrombocytopenic purpura: the Milan thrombotic thrombocytopenic purpura registry Agosti, Pasquale De Leo, Pasqualina Capecchi, Marco Ferrari, Barbara Mancini, Ilaria Gattillo, Salvatore Trisolini, Silvia Maria Rinaldi, Erminia Podda, Gian Marco Prezioso, Lucia Salutari, Prassede Facchini, Luca Caramazza, Domenica Tolomelli, Giulia Artoni, Andrea Peyvandi, Flora Res Pract Thromb Haemost Research Letter • Data on caplacizumab use for thrombotic thrombocytopenic purpura (TTP) in Italy are missing. • Twenty-six Italian patients were treated with caplacizumab for an acute immune TTP episode. • Caplacizumab was effective in treating acute TTP in the Italian real-world clinical setting. • Two major bleeds leading to drug discontinuation were observed. Elsevier 2023-08-26 /pmc/articles/PMC10502422/ /pubmed/37720483 http://dx.doi.org/10.1016/j.rpth.2023.102185 Text en © 2023 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Research Letter
Agosti, Pasquale
De Leo, Pasqualina
Capecchi, Marco
Ferrari, Barbara
Mancini, Ilaria
Gattillo, Salvatore
Trisolini, Silvia Maria
Rinaldi, Erminia
Podda, Gian Marco
Prezioso, Lucia
Salutari, Prassede
Facchini, Luca
Caramazza, Domenica
Tolomelli, Giulia
Artoni, Andrea
Peyvandi, Flora
Caplacizumab use for immune thrombotic thrombocytopenic purpura: the Milan thrombotic thrombocytopenic purpura registry
title Caplacizumab use for immune thrombotic thrombocytopenic purpura: the Milan thrombotic thrombocytopenic purpura registry
title_full Caplacizumab use for immune thrombotic thrombocytopenic purpura: the Milan thrombotic thrombocytopenic purpura registry
title_fullStr Caplacizumab use for immune thrombotic thrombocytopenic purpura: the Milan thrombotic thrombocytopenic purpura registry
title_full_unstemmed Caplacizumab use for immune thrombotic thrombocytopenic purpura: the Milan thrombotic thrombocytopenic purpura registry
title_short Caplacizumab use for immune thrombotic thrombocytopenic purpura: the Milan thrombotic thrombocytopenic purpura registry
title_sort caplacizumab use for immune thrombotic thrombocytopenic purpura: the milan thrombotic thrombocytopenic purpura registry
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10502422/
https://www.ncbi.nlm.nih.gov/pubmed/37720483
http://dx.doi.org/10.1016/j.rpth.2023.102185
work_keys_str_mv AT agostipasquale caplacizumabuseforimmunethromboticthrombocytopenicpurpurathemilanthromboticthrombocytopenicpurpuraregistry
AT deleopasqualina caplacizumabuseforimmunethromboticthrombocytopenicpurpurathemilanthromboticthrombocytopenicpurpuraregistry
AT capecchimarco caplacizumabuseforimmunethromboticthrombocytopenicpurpurathemilanthromboticthrombocytopenicpurpuraregistry
AT ferraribarbara caplacizumabuseforimmunethromboticthrombocytopenicpurpurathemilanthromboticthrombocytopenicpurpuraregistry
AT manciniilaria caplacizumabuseforimmunethromboticthrombocytopenicpurpurathemilanthromboticthrombocytopenicpurpuraregistry
AT gattillosalvatore caplacizumabuseforimmunethromboticthrombocytopenicpurpurathemilanthromboticthrombocytopenicpurpuraregistry
AT trisolinisilviamaria caplacizumabuseforimmunethromboticthrombocytopenicpurpurathemilanthromboticthrombocytopenicpurpuraregistry
AT rinaldierminia caplacizumabuseforimmunethromboticthrombocytopenicpurpurathemilanthromboticthrombocytopenicpurpuraregistry
AT poddagianmarco caplacizumabuseforimmunethromboticthrombocytopenicpurpurathemilanthromboticthrombocytopenicpurpuraregistry
AT preziosolucia caplacizumabuseforimmunethromboticthrombocytopenicpurpurathemilanthromboticthrombocytopenicpurpuraregistry
AT salutariprassede caplacizumabuseforimmunethromboticthrombocytopenicpurpurathemilanthromboticthrombocytopenicpurpuraregistry
AT facchiniluca caplacizumabuseforimmunethromboticthrombocytopenicpurpurathemilanthromboticthrombocytopenicpurpuraregistry
AT caramazzadomenica caplacizumabuseforimmunethromboticthrombocytopenicpurpurathemilanthromboticthrombocytopenicpurpuraregistry
AT tolomelligiulia caplacizumabuseforimmunethromboticthrombocytopenicpurpurathemilanthromboticthrombocytopenicpurpuraregistry
AT artoniandrea caplacizumabuseforimmunethromboticthrombocytopenicpurpurathemilanthromboticthrombocytopenicpurpuraregistry
AT peyvandiflora caplacizumabuseforimmunethromboticthrombocytopenicpurpurathemilanthromboticthrombocytopenicpurpuraregistry